UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Cape Investment Advisory Inc.

Cape Investment Advisory Inc. reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,633 shares of the healthcare conglomerate’s stock after selling 30 shares during the period. Cape Investment Advisory Inc.’s holdings in UnitedHealth Group were worth $826,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of UNH. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth $30,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth about $37,000. Legacy Investment Solutions LLC purchased a new stake in shares of UnitedHealth Group during the 3rd quarter worth about $57,000. DecisionPoint Financial LLC raised its holdings in UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after buying an additional 62 shares during the period. Finally, FPC Investment Advisory Inc. grew its stake in UnitedHealth Group by 863.6% during the fourth quarter. FPC Investment Advisory Inc. now owns 106 shares of the healthcare conglomerate’s stock worth $58,000 after buying an additional 95 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Barclays reduced their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Finally, KeyCorp reaffirmed an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Trading Up 1.4 %

UnitedHealth Group stock opened at $474.95 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm’s 50-day moving average is $516.59 and its 200-day moving average is $557.04. The company has a market cap of $437.09 billion, a P/E ratio of 30.64, a PEG ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the company earned $5.83 earnings per share. The business’s revenue was up 6.8% compared to the same quarter last year. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.77%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.33% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.